Abstract
Mesenchymal stem cells (MSCs) represent a new therapeutic paradigm for a number of diseases because they possess unique biological characteristics such as multipotency, immunomodulation and production of cytokines. Currently, 425 MSC based clinical trials have been conducted for at least 12 kinds of pathological conditions, with many completed trials demonstrating the safety and efficacy of MSCs. Here, we provide an overview of the clinical status of MSCs by searching the public clinical trials database http://clinicaltrials.gov. Particularly, the role of MSCs in clinical trials to treat bone defects and injuries is highlighted.
Keywords: Bone defects, clinical transition, differentiation, immunomodulation, mesenchymal stem cells, secretome.
Graphical Abstract
Current Molecular Pharmacology
Title:Mesenchymal Stem Cells and Cell Therapy for Bone Repair
Volume: 9
Author(s): Shihua Wang, Pengchao Xu, Xiaoxia Li, Xiaodong Su, Yunfei Chen, Li Wan, Linyuan Fan, Kan Yin, Yan Liu and Robert Chunhua Zhao
Affiliation:
Keywords: Bone defects, clinical transition, differentiation, immunomodulation, mesenchymal stem cells, secretome.
Abstract: Mesenchymal stem cells (MSCs) represent a new therapeutic paradigm for a number of diseases because they possess unique biological characteristics such as multipotency, immunomodulation and production of cytokines. Currently, 425 MSC based clinical trials have been conducted for at least 12 kinds of pathological conditions, with many completed trials demonstrating the safety and efficacy of MSCs. Here, we provide an overview of the clinical status of MSCs by searching the public clinical trials database http://clinicaltrials.gov. Particularly, the role of MSCs in clinical trials to treat bone defects and injuries is highlighted.
Export Options
About this article
Cite this article as:
Wang Shihua, Xu Pengchao, Li Xiaoxia, Su Xiaodong, Chen Yunfei, Wan Li, Fan Linyuan, Yin Kan, Liu Yan and Zhao Chunhua Robert, Mesenchymal Stem Cells and Cell Therapy for Bone Repair, Current Molecular Pharmacology 2016; 9 (4) . https://dx.doi.org/10.2174/1874467208666150928153758
DOI https://dx.doi.org/10.2174/1874467208666150928153758 |
Print ISSN 1874-4672 |
Publisher Name Bentham Science Publisher |
Online ISSN 1874-4702 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
CellSaic, A Cell Aggregate-Like Technology Using Recombinant Peptide Pieces for MSC Transplantation
Current Stem Cell Research & Therapy Virtual Screening for Novel Staphylococcus Aureus NorA Efflux Pump Inhibitors From Natural Products
Medicinal Chemistry Mediterranean Diet and Cardiovascular Disease
Current Nutrition & Food Science Somatostatin and its Analogs
Current Drug Targets A Review of the Recent Developments in Synthetic Anti-Breast Cancer Agents
Anti-Cancer Agents in Medicinal Chemistry ISCHEMIRs: Finding a Way Through the Obstructed Cerebral Arteries
Current Drug Targets New Frontiers in the Therapeutic Management of Transplant Rejection
Current Pharmaceutical Design A Protective Role of Translocator Protein in Alzheimer’s Disease Brain
Current Alzheimer Research Common Cellular and Molecular Mechanisms Underlying Alzheimer’s Disease and Type 2 Diabetes: A Knowledge-Driven Approach
CNS & Neurological Disorders - Drug Targets Mast Cells and Inflammatory Heart Disease: Potential Drug Targets
Cardiovascular & Hematological Disorders-Drug Targets Immunomodulatory Actions of Vitamin D Metabolites and their Potential Relevance to Human Lung Disease
Current Respiratory Medicine Reviews Treatment Failure in Ventilator Associated Pneumonia
Current Respiratory Medicine Reviews Bile Acids and Derivatives, Their Nuclear Receptors FXR, PXR and Ligands: Role in Health and Disease and Their Therapeutic Potential
Anti-Cancer Agents in Medicinal Chemistry Coxibs and Cardiovascular Side-Effects: From Light to Shadow
Current Pharmaceutical Design Respiratory Syncytial Virus Bronchiolitis and Asthma – Insights from Recent Studies and Implications for Therapy
Inflammation & Allergy - Drug Targets (Discontinued) Chymase Inhibitor As a Novel Therapeutic Strategy for Anti-Vascular Remodeling
Vascular Disease Prevention (Discontinued) Cancer Immunotherapy Using Gene-Modified Dendritic Cells
Current Gene Therapy Insights Into Entamoeba histolytica Virulence Modulation
Infectious Disorders - Drug Targets Selective COX-1 Inhibition: A Therapeutic Target to be Reconsidered
Current Medicinal Chemistry ABC Transporters in Multidrug Resistance and Pharmacokinetics, and Strategies for Drug Development
Current Pharmaceutical Design